High-intensity aerobic interval training and resistance training are feasible in rectal cancer patients undergoing chemoradiotherapy: a feasibility randomized controlled study

Piraux, Elise;Reychler, Gregory;Vancraeynest, David;Geets, Xavier;Caty, Gilles;et.al.
(2022) Reports on Practical Oncology and Radiotherapy — Vol. 27, n° 2, p. 198-208 (2022)

Files

88886-341088-1-PB.pdf
  • Open Access
  • Adobe PDF
  • 306.05 KB
Download

Details

Authors
Show more
Abstract
Background: There has been growing evidence of the benefits of high-intensity aerobic interval training (HIIT) and resistance training (RES) for populations with cancer. However, these two modalities have not yet been performed alone in rectal cancer patients undergoing neoadjuvant chemoradiotherapy (NACRT). Therefore, this study aimed to determine the feasibility of HIIT and RES in rectal cancer patients undergoing NACRT. Materials and methods: Rectal cancer patients set to undergo NACRT were randomly assigned to HIIT intervention, RES intervention, or the usual care. Feasibility of HIIT and RES was assessed by measuring recruitment rate, adherence (retention rate, attendance rate, and exercise sessions duration and intensity), and adverse events. Endpoints (changes in fatigue, health-related quality of life, depression, daytime sleepiness, insomnia, sleep quality, functional exercise capacity, and executive function) were assessed at baseline and at week 5. Results: Among the 20 eligible patients, 18 subjects were enrolled and completed the study, yielding a 90% recruitment rate and 100% retention rate. Attendance at exercise sessions was excellent, with 92% in HIIT and 88% in RES. No exercise-related adverse events occurred. Conclusion: This study demonstrated that HIIT and RES are feasible in rectal cancer patients undergoing NACRT.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Piraux, E., Reychler, G., Vancraeynest, D., Geets, X., Léonard, D., & Caty, G. (2022). High-intensity aerobic interval training and resistance training are feasible in rectal cancer patients undergoing chemoradiotherapy: a feasibility randomized controlled study. Reports on Practical Oncology and Radiotherapy, 27(2), 198-208. https://doi.org/10.5603/rpor.a2022.0036 (Original work published 2022)